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THE ROLE OF ANTIOXIDANTS IN NITRIC-OXIDE INDUCED 
APOPTOSIS IN VASCULAR SMOOTH MUSCLE CELLS 
Nicholas Rossi and Melina Kibbe* 
Biology Department, Illinois Wesleyan University 
Northwestern University 
Apoptosis of vascular smooth muscle cel ls (VSMC) has been identified as having an important 
role in the prevention of neointimal hyperplasia. This is due to the ability of NO to induce 
programmed cell death, or apoptosis, of VSMC following injury. While the regulation of VSMC 
apoptosis i s  complex and not fully understood, it has been shown that upon VSMC stimulation 
with NO there i s  upregulation of the tumor suppressor gene p53 .  Previous studies indicate that 
down-regulation of p53 results in an increase in cellular ROS. Since p53 is a transcription factor 
known to affect the transcription of antioxidant proteins, it has been speculated that increased 
ROS levels are a result of the absence of p53 transcribed antioxidant proteins. ROS levels in 
VSMC were measured using flow cytometry both at baseline and following NO exposure. At 
baseline, ROS levels were significantly higher in p53-1- than p53+1+ VSMC. In response to NO 
treatment, the ROS increase was more pronounced in p53-1- than p53+1+ VSMC. Western blot 
analysis was performed to identify which pro- and anti-oxidant proteins were affected. The 
antioxidant protein most differentially expressed between p53-1- and p53+1+ VSMC was 
peroxiredoxin (PRX)-III. Appropriately, PRX-III is a mitochondrion specific H202 scavenging 
enzyme and has been cited as a critical regulator of mitochondrial H202. The prospect of PRX­
III providing a p53 mediated protective effect in p53+1+ VSMC matches well with the current 
understanding of PRX-III ' s  role in mitochondria as well  as the model of NO-induced apoptosis. 
